Malaysia’s innovation agency, Agensi Inovasi Malaysia (AIM), has invested in Mardil Medical, a US-based medical devicemaker formed out of assets acquired from a failed start-up that raised more than $100m from a consortium including corporate venturing units. AIM led a $6.125m series B round in Mardil, which is trying to raise a further $5m. Mardil…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
